- Organizations: Roche
Pipeline
Roche reports phase 3 data on steroid-free therapy for UME management
Company announces FDA acceptance of BLA submission as 52-week results find vamikibart demonstrated sustained improvements in vision.Research
4-year data shows Vabymso delivers lasting DME results with fewer injections
Open-label extension study demonstrates long-term safety, efficacy, and tolerability of faricimab in DME patients.Products